Substantial preclinical as well as clinical evidence indicates that TGFβ plays a crucial role in promoting renal fibrosis, suggesting TGFβ to be a major therapeutic target in CKD patients (FIGURE 9). The gene discussed is TGFB1; the disease is chronic kidney disease.